The Translational Science Interagency Fellowship is a new postdoctoral fellowship opportunity. Fellows will be jointly mentored by NCATS and FDA scientists on a research project of mutual interest to both organizations. Fellows in this 3-year program will develop skills of value to future careers in academia, the pharmaceutical industry, and government. Applications due December 15, 2021.
The Translational Science Interagency Fellowship (TSIF) is a new postdoctoral fellowship opportunity developed by the National Center for Advancing Translational Sciences (NCATS) and the U.S. Food and Drug Administration (FDA).
Fellows will be jointly mentored by NCATS and FDA scientists on a research project of mutual interest to both organizations. Fellows in this program will develop skills of value to future careers in academia, the pharmaceutical industry, and government.
At the FDA, fellows will receive formal training and mentoring in:
- Relevant federal statutes, and
- Regulations, principles and practices of FDA medical product review.
At NCATS, fellows will receive formal training and mentoring in:
- The early stages of technology development, and
- Preclinical and clinical translational science.
For the 2022 class, there are nine projects spanning a wide range of topics (e.g., drug repurposing, predictive efficacy and toxicity, postmarketing surveillance, microphysiological systems).
This is a three-year program. September 2022 is the preferred start date. Applications due Dec. 15, 2021.
Applicants must be US citizens or permanent residents and have two years or less of postdoctoral training.
Questions about the fellowship and application process are welcome: TSIFellowship@nih.gov.